GSB Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.14M | Buy |
4,550
+95
| +2% | +$20.4K | 0.23% | 99 |
|
|
2026
Q1 | $969K | Sell |
4,455
-15
| -0.3% | -$3.33K | 0.22% | 104 |
|
|
2025
Q4 | $1.02M | Sell |
4,470
-1,331
| -23% | -$303K | 0.23% | 103 |
|
|
2025
Q3 | $1.34M | Sell |
5,801
-1,000
| -15% | -$204K | 0.3% | 87 |
|
|
2025
Q2 | $1.26M | Buy |
6,801
+13
| +0.2% | +$2.42K | 0.31% | 87 |
|
|
2025
Q1 | $1.42M | Sell |
6,788
-117
| -2% | -$22.7K | 0.37% | 87 |
|
|
2024
Q4 | $1.23M | Buy |
6,905
+9
| +0.1% | +$1.66K | 0.32% | 94 |
|
|
2024
Q3 | $1.36M | Buy |
6,896
+1,271
| +23% | +$237K | 0.35% | 88 |
|
|
2024
Q2 | $965K | Buy |
5,625
+25
| +0.4% | +$4.14K | 0.26% | 102 |
|
|
2024
Q1 | $1.02M | Buy |
5,600
+119
| +2% | +$20.5K | 0.29% | 101 |
|
|
2023
Q4 | $849K | Buy |
5,481
+1
| +0% | +$146 | 0.26% | 105 |
|
|
2023
Q3 | $817K | Buy |
5,480
+71
| +1% | +$10.4K | 0.27% | 101 |
|
|
2023
Q2 | $729K | Buy |
5,409
+99
| +2% | +$14.5K | 0.24% | 114 |
|
|
2023
Q1 | $846K | Sell |
5,310
-5,150
| -49% | -$787K | 0.28% | 111 |
|
|
2022
Q4 | $1.69M | Sell |
10,460
-1,586
| -13% | -$243K | 0.6% | 54 |
|
|
2022
Q3 | $1.62M | Buy |
12,046
+87
| +0.7% | +$12.5K | 0.59% | 59 |
|
|
2022
Q2 | $1.83M | Sell |
11,959
-2,370
| -17% | -$362K | 0.62% | 54 |
|
|
2022
Q1 | $2.32M | Sell |
14,329
-627
| -4% | -$91.1K | 0.68% | 47 |
|
|
2021
Q4 | $2.02M | Buy |
14,956
+3,406
| +29% | +$402K | 0.58% | 53 |
|
|
2021
Q3 | $1.25M | Sell |
11,550
-1,256
| -10% | -$144K | 0.64% | 50 |
|
|
2021
Q2 | $1.44M | Buy |
12,806
+1,800
| +16% | +$203K | 0.45% | 76 |
|
|
2021
Q1 | $1.19M | Buy |
+11,006
| New | +$1.18M | 0.4% | 84 |
|
|
2020
Q4 | – | Sell |
-2,701
| Closed | -$237K | – | 49 |
|
|
2020
Q3 | $237K | Hold |
2,701
| – | – | 1.08% | 42 |
|
|
2020
Q2 | $265K | Hold |
2,701
| – | – | 1.48% | 29 |
|
|
2020
Q1 | $206K | Hold |
2,701
| – | – | 1.5% | 34 |
|
|
2019
Q4 | $239K | Hold |
2,701
| – | – | 0.98% | 40 |
|
|
2019
Q3 | $205K | Buy |
+2,701
| New | +$185K | 1% | 50 |
|
|
2019
Q2 | – | Sell |
-2,701
| Closed | -$218K | – | 51 |
|
|
2019
Q1 | $218K | Hold |
2,701
| – | – | 0.93% | 48 |
|
|
2018
Q4 | $249K | Hold |
2,701
| – | – | 1.31% | 35 |
|
|
2018
Q3 | $255K | Hold |
2,701
| – | – | 1.05% | 44 |
|
|
2018
Q2 | $250K | Hold |
2,701
| – | – | 1.18% | 41 |
|
|
2018
Q1 | $256K | Hold |
2,701
| – | – | 1.23% | 37 |
|
|
2017
Q4 | $261K | Hold |
2,701
| – | – | 1.17% | 40 |
|
|
2017
Q3 | $240K | Buy |
+2,701
| New | +$206K | 1.14% | 43 |
|
Other funds holding ABBV
GSB Wealth Management's ABBV Position: Q2 2026 in Review
GSB Wealth Management increased its AbbVie (ABBV) stake by 2.1% in Q2 2026, buying an estimated $20.4K and bringing the position to 4,550 shares worth $1.14M. The position accounts for 0.23% of the portfolio, ranked #99.
GSB Wealth Management first reported a position in ABBV in Q3 2017 and has held it in 34 quarters since. The position peaked at $2.32M in Q1 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- GSB Wealth Management held 4,550 shares of AbbVie worth $1.14M as of Q2 2026.
- GSB Wealth Management bought 95 AbbVie shares in Q2 2026, an estimated $20.4K.
- AbbVie made up 0.23% of GSB Wealth Management's portfolio in Q2 2026, its #99 holding.
- GSB Wealth Management first reported a position in AbbVie in Q3 2017 and has held it in 34 quarters since.
- GSB Wealth Management's AbbVie position peaked at $2.32M in Q1 2022.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on GSB Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.